Skip to content
Home/Companies/Biotech/T-Therapeutics
TT

T-Therapeutics

Biotech·UK·Active·3yr hold

T-Therapeutics is a healthcare / biotech company, headquartered in United Kingdom.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns T-Therapeutics?

T-Therapeutics is currently owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage), since 2023. Across its history, T-Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Cambridge Innovation Capital
Most recent investor
Cambridge Innovation Capital
CIC Fund II · 2022 · VC
3 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorHealthcare / Biotech

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by Sofinnova Partners, Cambridge Innovation Capital and BGF since 2023.
Co-invest · 3 holders · 2023 · present
Sofinnova Partners
Sofinnova PartnersActive
2023 · present · Sofinnova Capital X · 2021 · Life Sciences VC
MOIC
–
Cambridge Innovation Capital
Cambridge Innovation CapitalActive
2023 · present · CIC Fund II · 2022 · VC
MOIC
–
BGF
BGFActive
2025 · present · BGF · 2011 · Evergreen
MOIC
–

More from CIC Fund II

Other portfolio companies in the same fund.

Immutrin
Active
BiotechUK· 2025
TRIMTECH Therapeutics
Active
BiotechUK· 2025
Forefront RF
Active
TelecomUK· 2024
Nuclera
Active
BiotechUnited Kingdom· 2024
Complement Therapeutics
Active
BiotechUK· 2023
Mosaic TX
Active
BiotechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings